An N-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells-Reference-Cited by-同舟云学术

An N-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells

Published:2019-02 Issue: Volume:160 Page:134-145
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Uddin Mohammad B.^ORCID,Roy Kartik R.,Hosain Salman B.,Khiste Sachin K.,Hill Ronald A.,Jois Seetharama D.,Zhao Yunfeng,Tackett Alan J.,Liu Yong-Yu^ORCID

Funder

National Institutes of Health

National Cancer Institute

National Institute of General Medical Sciences

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference53 articles.

1. Census and evaluation of p53 target genes;Fischer;Oncogene,2017

2. Cancer p53, guardian of the genome;Lane;Nature,1992

3. The p53 pathway: positive and negative feedback loops;Harris;Oncogene,2005

4. Ferroptosis as a p53-mediated activity during tumour suppression;Jiang;Nature,2015

5. TP53: an oncogene in disguise;Soussi;Cell Death Differ.,2015

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refining the role of N6-methyladenosine in cancer;Current Opinion in Genetics & Development;2024-10

2. LncRNA CARMN m6A demethylation by ALKBH5 inhibits mutant p53‐driven tumour progression through miR‐5683/FGF2;Clinical and Translational Medicine;2024-07

3. N6-methyladenosine-dependent signaling in colorectal cancer: Functions and clinical potential;Critical Reviews in Oncology/Hematology;2024-06

4. Homozygous EPRS1 missense variant causing hypomyelinating leukodystrophy-15 alters variant-distal mRNA m6A site accessibility;Nature Communications;2024-05-20

5. Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy;Cancer Medicine;2024-03-28